Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by jimsenior


T.ONC

RE:"Griproom" article - 10 signs your company is to be acquired

I have been looking for such advice, and have bookmarked this. Just finished...

November 19, 2022

T.ONC

RE:RE:RE:RE:RE:Roche experiences second failure in Alzheimer's disease

Thank you for mentioning the interview. By far the best performance by MC; it...

November 15, 2022

T.ONC

RE:RE:It is frustrating...

I think you will find the poster under technology  -  website. I...

November 15, 2022

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Using the ATM or

Thank you for your posts. This question is likely naive; given GOBLET is...

November 14, 2022

T.ONC

RE:RE:Reading this board you would think we would be flying out of

If it has not started I suppose that could be good or bad. Has it started; I...

November 14, 2022

T.ONC

RE:Reading this board you would think we would be flying out of

Has KOL begun.

November 14, 2022

T.ONC

RE:RE:RE:RE:Pelareorep Cost

Name changed to MilliporeSigma, Carlsbad, California.

November 12, 2022

T.ONC

RE:RE:RE:Pelareorep Cost

Manufactured by Sigma-Aldrich, owned by Merck. Carlsbad . I do not think it...

November 12, 2022

T.ONC

RE:RE:Could the volume here get any lower???????

I was looking at GOBLET from my lay perspective; that is to say with very...

November 4, 2022

T.ONC

RE:A couple months before! It’s why I’m here!

Of Note. Houra Loghmani, Senior Scientist, Translational Oncology, Oncolytics...

November 4, 2022

T.ONC

RE:RE:RE:RE:ONCY pelareorep + CD3 bispecific antibody true-killer combo

A layman's look at ONC & Multiple Myeloma. In numerical order from...

November 3, 2022

T.ONC

RE:RE:RE:RE:Pfizer response to questions on M&A -> add value to company

There were 2 releases on that date. Preclinical Data is the one of interest...

November 1, 2022

T.ONC

RE:RE:RE:Pfizer response to questions on M&A -> add value to company

See ONC Press Release April 12, 2021

November 1, 2022

T.ONC

RE:RE:Pfizer response to questions on M&A -> add value to company

Nota Bene  -  Pfizer's NICE approval.

November 1, 2022

T.ONC

RE:RE:RE:Roche reports Q3 earnings - looks to Tecentriq for future

Do not know who sold them to me, but I bought 800 shares through TD. ...

October 31, 2022

T.ONC

RE:Roche reports Q3 earnings - looks to Tecentriq for future

Added some shares this morning! Bonne chance.

October 31, 2022

T.ONC

RE:Jimsenior ...

Thank you. I was not upset, other than the fact one does not like being in...

October 22, 2022

T.ONC

RE:RE:RE:RE:RE:RE:RE:Simply Wealthy

One last attempt. You have been posting relentlessly for many years now, here...

October 21, 2022

T.ONC

RE:RE:RE:RE:RE:Simply Wealthy

That is not my intention. I mentioned simplywallstreet because their report...

October 21, 2022

T.ONC

RE:RE:RE:Simply Wealthy

Yes. I fully agree the Biohaven model is doable. To digress, the SimplyWall...

October 21, 2022

Prev 1 2 3 4 5 6 7 8 9 10 11 12 Next

Featured Company